Aging clinical trials
84 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)
- Pilot Intervention With Near Infrared Stimulation
- Transcranial Pulse Stimulation of the Brain
- Speech Perception and High Cognitive Demand
- Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI
- BID WM Digital Intervention in Aging
- Empagliflozin Reversal of Arterial StiffnEss in Aging
- Ongoing Lung Decline With Age Intensified Response
- Brain Research Assessing Impacts of Neurophysiological Processing Speed Training in Veterans
- Ischemic Conditioning to Promote Microvascular Resiliency in Frail Individuals
- Inspiring Seniors Towards Exercise Promotion - 2
- Gene Expression Changes In Young and Geriatric Skin
- The Role of Sirolimus in Preventing Functional Decline in Older Adults
- Exercise to Improve Brain Health in Older African Americans
- Emotional Well-being and Measures of Healthy Aging
- Tirzepatide to Slow Biological Aging
- Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
- Breaking Sitting with High-intensity Interval Training for Brain Health
- Guided Episodic Future Thinking to Increase Physical Activity Adherence and Promote Healthy Brain Aging
- Foot Strengthening to Improve Balance and Gait in Older Adults
- Mode of Exercise and Bone Biomarkers in Older Veterans
- Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities
- MTOR Inhibitors in Older Adults
- Artificial Intelligence-Based Health Assessment From Face Photographs - Healthy Volunteer Study
- Memory Enhancement in Aging With Optimal Dosing
- Mental Effort During Low Load Resistance Training in Older Adults
- Restructuring the Alpha-Gamma Code in Aging Vision
- Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
- Arlington Aging Study
- Mechanisms of Anabolic Resistance in Older Humans
- Molecular Optimization Via Exercise (MOVE)
- Metabolic and Functional Consequences of Aging in Health and Disease
- Postural Control During Concurrent Cognitive Tasks During Optic Flow Stimulation
- Technical Development of Multi-Parametric Renocerebral MRI
- Baltimore Longitudinal Study of Aging
- Fiber and Calcium Absorption in Older Men
- Neural Control of Gait & Navigation in ADRD
- Human Observatory Study
- Apple Health Study
- Rapalog Pharmacology (RAP PAC) Study
- RESTOR: PK/PD mTORi Inhibition in Older Adults
- The Effect of NAD Supplementation on Brain Vascular Health in Aging
- The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults
- Angiotensin-(1-7) Cardiovascular Effects in Aging
- Using Nicotine to Reverse Age-related Auditory Processing Deficits
- The Role of the Locus Coeruleus in Age-related Distractibility
- Optimizing Strength Training in Older Adults
- Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
- Effects of Obesity in the Aged
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Aging” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.